BusinessNovelion Therapeutics Strengthens Leadership Team with Appointment of Murray Stewart, M.D., as Executive Vice President, Head of R&DBy Nasdaq OMXOct 12, 2017, 1:15 PM UTC
BusinessNovelion Therapeutics Announces Presentation of Metreleptin Data at American Association of Clinical EndocrinologyBy Nasdaq OMXMay 5, 2017, 1:01 PM UTC
BusinessNovelion Therapeutics Announces Presentation of Metreleptin Data at American Association of Clinical EndocrinologyBy Nasdaq OMXMay 5, 2017, 1:01 PM UTC
BusinessNovelion Therapeutics’ Subsidiary Launches JUXTAPID® (lomitapide) in JapanBy Nasdaq OMXDec 16, 2016, 1:36 PM UTC